Natalia Colocci

451 total citations
17 papers, 314 citations indexed

About

Natalia Colocci is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Natalia Colocci has authored 17 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Natalia Colocci's work include Palliative Care and End-of-Life Issues (5 papers), Patient Dignity and Privacy (3 papers) and Viral-associated cancers and disorders (3 papers). Natalia Colocci is often cited by papers focused on Palliative Care and End-of-Life Issues (5 papers), Patient Dignity and Privacy (3 papers) and Viral-associated cancers and disorders (3 papers). Natalia Colocci collaborates with scholars based in United States, Canada and United Kingdom. Natalia Colocci's co-authors include Edie Weller, Thomas M. Habermann, Howard S. Höchster, Leo I. Gordon, Sandra J. Horning, Randy D. Gascoyne, Stanley Frankel, Lijun Zhang, Theresa Ryan and Lawrence D. Recht and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Natalia Colocci

14 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalia Colocci United States 7 226 171 128 68 45 17 314
Giorgia Annechini Italy 10 147 0.7× 132 0.8× 73 0.6× 60 0.9× 66 1.5× 25 287
Mohammed Al‐Hamadani United States 5 178 0.8× 170 1.0× 77 0.6× 49 0.7× 24 0.5× 10 302
Maya Hacini France 6 285 1.3× 189 1.1× 114 0.9× 81 1.2× 35 0.8× 15 358
Lindsey Stevens United Kingdom 5 286 1.3× 211 1.2× 99 0.8× 63 0.9× 7 0.2× 15 328
Pär Josefsson Denmark 10 252 1.1× 124 0.7× 179 1.4× 41 0.6× 27 0.6× 18 369
Michaela Rancea Germany 5 236 1.0× 144 0.8× 73 0.6× 91 1.3× 14 0.3× 11 301
Viola Pöschel Germany 7 235 1.0× 186 1.1× 75 0.6× 108 1.6× 25 0.6× 8 293
KM Ardeshna United Kingdom 2 336 1.5× 259 1.5× 141 1.1× 64 0.9× 10 0.2× 3 377
Ulla Martinsson Sweden 10 85 0.4× 92 0.5× 108 0.8× 24 0.4× 79 1.8× 24 302
Mark D. Sborov United States 6 166 0.7× 184 1.1× 88 0.7× 32 0.5× 5 0.1× 8 254

Countries citing papers authored by Natalia Colocci

Since Specialization
Citations

This map shows the geographic impact of Natalia Colocci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Colocci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Colocci more than expected).

Fields of papers citing papers by Natalia Colocci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalia Colocci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Colocci. The network helps show where Natalia Colocci may publish in the future.

Co-authorship network of co-authors of Natalia Colocci

This figure shows the co-authorship network connecting the top 25 collaborators of Natalia Colocci. A scholar is included among the top collaborators of Natalia Colocci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia Colocci. Natalia Colocci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nabavizadeh, Nima, Christina G. McDonnell, Marc Matrana, et al.. (2025). LBA64 Safety and performance of a multi-cancer early detection (MCED) test in an intended-use population: Initial results from the registrational PATHFINDER II study. Annals of Oncology. 36. S1605–S1605.
2.
Martinez, Meghan C., Ellis C. Dillon, Amandeep Mann, et al.. (2025). A mixed-methods study of communication preferences and experiences from diagnosis to death as reported by patients with advanced cancer and their family caregivers. Patient Education and Counseling. 141. 109315–109315.
3.
Dillon, Ellis C., Amandeep Mann, Su‐Ying Liang, et al.. (2025). Quality Improvement Effort With Proactive Social Worker Communication to Enhance Palliative Care Access. JCO Oncology Practice. OP2500077–OP2500077. 1 indexed citations
5.
Liang, Su‐Ying, Michael Richardson, Deanna H. Wong, et al.. (2022). The effect of COVID‐19 on telehealth: Next steps in a post‐pandemic life. International Journal of Gynecology & Obstetrics. 159(3). 996–997.
6.
Dillon, Ellis C., et al.. (2021). Breast Cancer Navigation: Using Physician and Patient Surveys to Explore Nurse Navigator Program Experiences. Clinical journal of oncology nursing. 25(5). 579–586. 4 indexed citations
7.
Liang, Su‐Ying, Michael Richardson, Tony Chen, et al.. (2021). Widening cancer care disparities in the adoption of telemedicine during COVID 19: who is left behind?. Gynecologic Oncology. 162. S23–S23. 3 indexed citations
8.
Dillon, Ellis C., Amy Meehan, Jinnan Li, et al.. (2020). How, when, and why individuals with stage IV cancer seen in an outpatient setting are referred to palliative care: a mixed methods study. Supportive Care in Cancer. 29(2). 669–678. 10 indexed citations
9.
Dillon, Ellis C., et al.. (2020). Evolving Goals of Care Discussions as Described in Interviews With Individuals With Advanced Cancer and Oncology and Palliative Care Teams. American Journal of Hospice and Palliative Medicine®. 38(7). 785–793. 16 indexed citations
11.
Höchster, Howard S., Edie Weller, Randy D. Gascoyne, et al.. (2009). Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study. Journal of Clinical Oncology. 27(10). 1607–1614. 193 indexed citations
12.
Colocci, Natalia, et al.. (2007). Adjuvant docetaxel chemotherapy with abbreviated hormonal therapy in patients with high-risk prostate cancer. Journal of Clinical Oncology. 25(18_suppl). 15589–15589. 1 indexed citations
13.
Srinivas, Sandy & Natalia Colocci. (2006). Nonplatinum therapy in advanced bladder cancer. Expert Review of Anticancer Therapy. 6(6). 887–894. 4 indexed citations
14.
Srinivas, Sandy, Aruna V. Krishnan, Natalia Colocci, & David Feldman. (2006). Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer. Urology. 67(5). 1001–1006. 3 indexed citations
15.
Srinivas, Sandy & Natalia Colocci. (2006). Bone Related Events in High Risk Prostate Cancer. The Journal of Urology. 176(6S). S50–4. 10 indexed citations
16.
Colocci, Natalia, Edie Weller, H. S. Hochster, et al.. (2005). Prognostic significance of the follicular lymphoma international prognostic index (FLIPI) in the E1496 trial of chemotherapy with or without maintenance rituximab. Journal of Clinical Oncology. 23(16_suppl). 6526–6526. 4 indexed citations
17.
Colocci, Natalia, Michael Glantz, & Lawrence D. Recht. (2004). Prevention and Treatment of Central Nervous System Involvement by Non-Hodgkin's Lymphoma: A Review of the Literature. Seminars in Neurology. 24(4). 395–404. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026